(2-(Morpholine-4-carbonyl)phenyl)boronic acid

Catalog No. :
ACOPLX385
CAS No. :
874219-17-7
Molecular Formula :
C11H14BNO4
Molecular Weight :
235.05

IUPAC Name:(2-(morpholine-4-carbonyl)phenyl)boronic acid

(2-(Morpholine-4-carbonyl)phenyl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg96%$175.00Login to see priceInquiryInquiry
1g96%$417.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2-(Morpholine-4-carbonyl)phenyl)boronic acid
IUPAC Name(2-(morpholine-4-carbonyl)phenyl)boronic acid
MDL No.MFCD08235036
Molecular FormulaC11H14BNO4
Molecular Weight235.05
SMILESO=C(C1=CC=CC=C1B(O)O)N2CCOCC2
InChI KeyDUXSLRIREWOQJJ-UHFFFAOYSA-N
Synonym874219-17-7 | (2-(Morpholine-4-carbonyl)phenyl)boronic acid | 2-(Morpholine-4-carbonyl)phenylboronic acid | [2-(morpholine-4-carbonyl)phenyl]boronic acid | 2-(Morpholin-4-ylcarbonyl)benzeneboronic acid | (2-(Morpholine-4-carbonyl)phenyl)boronicacid | Boronic acid,B-[
CAS No.874219-17-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOPLX385 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJLSG472 route compound structure diagram
    ACJLSG472914454-08-3 In Stock
  4. Then
  5. ACOPLX385 route product structure diagram
    ACOPLX385874219-17-7
Inquiry

2. ACOPLX385 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOPLX385 route product structure diagram
    ACOPLX385874219-17-7
Inquiry

Comments (0)